Jackson Creek Investment Advisors’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$619K Sell
2,465
-657
-21% -$141K 0.21% 200
2026
Q1
$679K Sell
3,122
-7
-0.2% -$1.55K 0.2% 176
2025
Q4
$715K Sell
3,129
-101
-3% -$23K 0.21% 175
2025
Q3
$748K Sell
3,230
-26
-0.8% -$5.29K 0.22% 175
2025
Q2
$604K Sell
3,256
-26
-0.8% -$4.83K 0.16% 212
2025
Q1
$688K Buy
+3,282
New +$638K 0.22% 207
2024
Q2
Sell
-2,038
Closed -$371K 300
2024
Q1
$371K Buy
2,038
+603
+42% +$104K 0.13% 268
2023
Q4
$222K Hold
1,435
0.09% 293
2023
Q3
$214K Buy
+1,435
New +$211K 0.09% 293
2022
Q2
Sell
-1,985
Closed -$322K 299
2022
Q1
$322K Hold
1,985
0.12% 280
2021
Q4
$269K Hold
1,985
0.1% 280
2021
Q3
$214K Sell
1,985
-78
-4% -$8.91K 0.08% 290
2021
Q2
$232K Buy
+2,063
New +$232K 0.09% 287

Other funds holding ABBV

Jackson Creek Investment Advisors's ABBV Position: Q2 2026 in Review

Jackson Creek Investment Advisors reduced its AbbVie (ABBV) stake by 21% in Q2 2026, selling an estimated $141K and leaving 2,465 shares worth $619K. The position accounts for 0.21% of the portfolio, ranked #200.

Jackson Creek Investment Advisors first reported a position in ABBV in Q2 2021 and has held it in 13 quarters since. The position peaked at $748K in Q3 2025. 4,194 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Jackson Creek Investment Advisors held 2,465 shares of AbbVie worth $619K as of Q2 2026.
  • Jackson Creek Investment Advisors sold 657 AbbVie shares in Q2 2026, an estimated $141K.
  • AbbVie made up 0.21% of Jackson Creek Investment Advisors's portfolio in Q2 2026, its #200 holding.
  • Jackson Creek Investment Advisors first reported a position in AbbVie in Q2 2021 and has held it in 13 quarters since.
  • Jackson Creek Investment Advisors's AbbVie position peaked at $748K in Q3 2025.
  • 4,194 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Jackson Creek Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.